Direct-to-consumer prescription drug advertising: Understanding its consequences

International Journal of Advertising

Volumn 24, Issue 4, 2005, Pages 443-468

  Huh, Jisu ^a   Becker, Lee B ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749355753     PISSN: 02650487     EISSN: None     Source Type: Journal    
DOI: 10.1080/02650487.2005.11072938     Document Type: Article

References (27)

1. Aaker, D.A. & Myers, J.G. (1975) Advertising Management. Englewood Cliffs, NJ: Prentice-Hall.
2. Alperstein, N.M. & Peyrot, M. (1993) Consumer awareness of prescription drug advertising. Journal of Advertising Research, 33(4), pp. 50–56.
3. Balazs, A.L., Yermolovich, J. & Zinkhan, G.M. (2000) Direct to consumer advertising: an ad processing perspective. Marketing in a Global Economy Proceedings.
4. Blankenhorn, K. & Lipson, D. (2002) Business watch, 2001 in review: despite economic challenges, pharmaceutical industry still maintains steady growth. Medical Marketing & Media, 37, May, pp. 46–62.
5. Calfee, J.E. (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21(2), pp. 174–193.
6. Colley, R. (1961) Defining Advertising Goals for Measured Advertising Results. New York: Association of National Advertisers.
7. Davis, J.J. (2000) Riskier than we think? The relationship between risk statement completeness and perceptions of direct consumer advertised prescription drugs. Journal of Health Communication, 5(4), pp. 349–369.
8. Findlay, S.D. (2001) Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers. Pharmacoeconomics, 19(2), pp. 109–119.
9. Harris, R.J. (1983) Information Processing Research in Advertising. Hillsdale, NJ: Lawrence Erlbaum Associates, p. 8.
10. Hollon, M.F. (1999) Direct-to-consumer marketing of prescription drugs: creating consumer demand. The Journal of the American Medical Association, 281(4), p. 382.
11. Holtz, W.E. (1998) Consumer-directed prescription drug advertising: effects on public health. Journal of Law and Health, 13(2), pp. 199–218.
12. Kaiser Family Foundation (2001) Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising. Menlo Park, CA, November.
13. Lavidge, R.J. & Steiner, G.A. (1961) A model for predictive measurements of advertising effectiveness. Journal of Marketing, 25(6), pp. 59–62.
14. Lexchin, J. & Mintzes, B. (2002) Direct-to-consumer advertising of prescription drugs: the evidence says no. Journal of Public Policy & Marketing, 21(2), pp. 194–201.
15. MacKenzie, S.B. & Lutz, R.J. (1989) An empirical examination of the structural antecedents of attitude toward the ad in an advertising pretesting context. Journal of Marketing, 53, April, pp. 48–65.
16. McGuire, W.J. (1978) An information processing model of advertising effectiveness. In: Davis, H.L. & Silk, A.J. (eds) Behavioral and Management Science in Marketing. New York: Ronald Press.
17. McInturff, B. (2001) Consumers see benefit in what they see, read. Advertising Age, 26 March, p. 24.
18. Perri, M. III & Nelson, A.A. Jr (1987) An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. Journal of Health Care Marketing, 7(1), pp. 9–17.
19. Perri, M.W. & Dickson, M. (1988) Consumer reaction to a direct-to-consumer prescription drug advertising campaign. Journal of Health Care Marketing, 8(2), pp. 66–69.
20. Peyrot, M., Alperstein, N.M., Doren, D.V. & Poli, L.G. (1998) Direct-to-consumer ads can influence behavior. Marketing Health Services, Summer, 18(2), pp. 26–32.
21. Pfizer, Inc. (2001) Direct-to-Consumer Advertising: How it Benefits Consumers, June. Rogers, A. (1986) Prescription drug ads still cloudy. Adweek, 28 April.
22. Sengupta, S. (2002) Prescription drug advertising: the effectiveness of pitching directly to consumers. Association for Education in Journalism and Mass Communication Conference.
23. Siegel, L. (2000) DTC advertising: bane … or blessing? A 360-degree view. Pharmaceutical Executive, 20(10), pp. 140–152.
24. US General Accounting Office (2003) Prescription Drugs: FDA Oversight of Direct-to- Consumer Drug Advertising Has Limitations, pp. 3–5.
25. West, D. (2005) Changing lanes. Pharmaceutical Executive, 25(5), pp. 154–159.
26. Wilkes, M.S., Bell, R.A. & Kravitz, R.L. (2000) Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 19(2), pp. 110–128.
27. Williams, J.R. & Hensel, P.J. (1995) Direct-to-consumer advertising of prescription drugs. Journal of Health Care Marketing, 15(1), pp. 35–41.